Literature DB >> 9065618

Clinical and immunohistochemical analyses of parotid gland tumors.

W Ozdziński1, J Kuczkowski, E Debniak, A Zołtowska.   

Abstract

Clinical, histological and immunohistochemical data on 71 parotid gland tumors were analyzed. Benign neoplasms accounted for 71.8% of the case material and malignant tumors 22.6%. Chronic parotitis occurred in 5.6% of the total case number. Pleomorphic adenomas and mucoepidermoid carcinomas were the most frequently occurring benign and malignant neoplasms. Pleomorphic adenomas stained positive for S-100 protein, tenascin, smooth muscle actin, synaptophysin and chromogranin A. This immunohistochemical, histological and clinical analysis was believed to be of potential assistance in the diagnosis, treatment and prognosis of parotid gland tumors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9065618     DOI: 10.1007/bf02439714

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  4 in total

1.  Tenascin in salivary gland tumours.

Authors:  Y Soini; P Pääkkö; I Virtanen; V P Lehto
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

Review 2.  Malignant myoepithelial carcinoma (myoepithelioma) arising in a pleomorphic adenoma of the parotid gland. An immunohistochemical study and review of the literature.

Authors:  R Singh; R A Cawson
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1988-07

3.  Tumor-associated glycoprotein distribution detected by monoclonal antibody B72.3 in salivary neoplasia.

Authors:  M S Brandwein; A G Huvos; J Patil; J Jagirdar
Journal:  Cancer       Date:  1992-06-01       Impact factor: 6.860

4.  Histopathologic studies on carcinoma in pleomorphic adenoma of the parotid gland.

Authors:  K Nagao; O Matsuzaki; H Saiga; I Sugano; H Shigematsu; T Kaneko; T Katoh; T Kitamura
Journal:  Cancer       Date:  1981-07-01       Impact factor: 6.860

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.